Staff
Personnel at the end of the year
Staff turnover in EUR
Turnover Label
The stock: denominated in EURO
Shares outstanding (in millions)
Dividend per share
Undiluted earnings per share
Boss v Mio. EURO nach IAS / IFRS
Turnover
Operating income (EBIT)
Profit before tax (EBT)
Annual net profit/ loss
Balance sheet in millions of Euro IAS / IFRS
Assets
Total current assets
Total fixed assets
Total assets
Liabilities
Total short-term liabilities
Total long-term liabilities
Total provisions
Equity capital
Total liabilities
Management:
Adriaan Moelker
Michael Schneiders
Board:
Michael Majerus
Anna Carina Eichhorn
Florian Schnabel
Ursula La Cognata
Christine Uekert
Stephen Catling
Shareholding in %:
Daniel Hopp 5.6
Deka Investment GmbH 1.89
FPM Frankfurt Performance Management AG 1.71
Generali Investments LLC 0.17
Joh. Berenberg, Gossler & Co. KG (Investment Management) 0.92
KBC Asset Management NV 0.27
MEAG MUNICH ERGO Kapitalanlagegesellschaft mbH 1.51
Martin Putsch 46.56
SMS & Cie. Vermögensmanagement GmbH 0.09
Universal-Investment-Gesellschaft mbH (Invt Mgmt) 2.99
Freefloat 38.29
Address: Darmstädter Strasse 34-36, 64673 Zwingenberg
T: +49-6251-9331-0
F: +
I: http://www.brain-biotech.de
E: public@brain-biotech.de